Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
Clinical trial NCT03237065 · COMPLETED
Trial details
- NCT number
- NCT03237065
- Sponsor
- Pharmacosmos A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2018-05-29
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.